Lei Yuguo, Jeong Daeun, Xiao Jifang, Schaffer David V
Department of Chemical and Biomolecular Engineering, University of California, Berkeley, Berkeley, California, 94720, USA ; Department of Bioengineering, University of California, Berkeley, Berkeley, California, 94720, USA ; California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, California, 94720, USA ; Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California, 94720, USA.
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, 94720, USA.
Cell Mol Bioeng. 2014 Jun;7(2):172-183. doi: 10.1007/s12195-014-0333-z.
Human pluripotent stem cells (hPSCs) - including embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) - are very promising candidates for cell therapies, tissue engineering, high throughput pharmacology screens, and toxicity testing. These applications require large numbers of high quality cells; however, scalable production of human pluripotent stem cells and their derivatives at a high density and under well-defined conditions has been a challenge. We recently reported a simple, efficient, fully defined, scalable, and good manufacturing practice (GMP) compatible 3D culture system based on a thermoreversible hydrogel for hPSC expansion and differentiation. Here, we describe additional design rationale and characterization of this system. For instance, we have determined that culturing hPSCs as a suspension in a liquid medium can exhibit lower volumetric yields due to cell agglomeration and possible shear force-induced cell loss. By contrast, using hydrogels as 3D scaffolds for culturing hPSCs reduces aggregation and may insulate from shear forces. Additionally, hydrogel-based 3D culture systems can support efficient hPSC expansion and differentiation at a high density if compatible with hPSC biology. Finally, there are considerable opportunities for future development to further enhance hydrogel-based 3D culture systems for producing hPSCs and their progeny.
人类多能干细胞(hPSC)——包括胚胎干细胞(hESC)和诱导多能干细胞(hiPSC)——是细胞治疗、组织工程、高通量药理学筛选和毒性测试中非常有前景的候选者。这些应用需要大量高质量的细胞;然而,在明确的条件下以高密度可扩展地生产人类多能干细胞及其衍生物一直是一个挑战。我们最近报道了一种基于热可逆水凝胶的简单、高效、完全明确、可扩展且符合药品生产质量管理规范(GMP)的3D培养系统,用于hPSC的扩增和分化。在此,我们描述该系统的更多设计原理和特性。例如,我们已经确定,由于细胞团聚和可能的剪切力诱导的细胞损失,将hPSC作为悬浮液培养在液体培养基中可能会表现出较低的体积产量。相比之下,使用水凝胶作为3D支架来培养hPSC可减少聚集,并可能使细胞免受剪切力影响。此外,如果与hPSC生物学特性兼容,基于水凝胶的3D培养系统可以支持hPSC在高密度下的高效扩增和分化。最后,未来还有相当多的发展机会来进一步改进基于水凝胶的3D培养系统,以生产hPSC及其后代。